Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 5 More Arrow 21 Less Arrow 3
Earnings before taxes -1,081 Less Arrow -2,139 Less Arrow -2,204
EBITDA -1,101 Less Arrow -2,159 Less Arrow -2,228
Total assets 806 More Arrow 1,956 Less Arrow 1,721
Current assets 314 More Arrow 1,447 Less Arrow 1,213
Current liabilities 134 More Arrow 392 Less Arrow 271
Equity capital 598 More Arrow 1,488 Less Arrow 1,373
- share capital 495 Less Arrow 372 Less Arrow 162
Employees (average) 2 More Arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 74.2% More Arrow 76.1% More Arrow 79.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -133.5% More Arrow -108.3% Less Arrow -127.9%
Current ratio 234.3% More Arrow 369.1% More Arrow 447.6%
Return on equity (ROE) -180.8% More Arrow -143.8% Less Arrow -160.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 Equal arrow 0
Chg. No. of employees % -33% More Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.